Read More Pharma Industry News Achilles Therapeutics shares skyrocket 32% after massive cost cuts—Is this the turnaround it needs? Achilles Therapeutics PLC saw its American Depositary Receipts (ADRs) soar by an impressive 32%, reflecting renewed investor optimism… byPallavi MadhirajuSeptember 19, 2024